Sunday, September 25, 2022 | Back issues
Courthouse News Service Courthouse News Service

Retrophin Inc. v. Questcor Pharmaceuticals Inc.

Questcor's unlawful acquisition of the rights to the drug Synacthen has entrenched its monopoly, Retrophin claims.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...